état (1) mutation (1) gène (1) enrichissement (1) dosage (1) maladie (1) abords (agglomération) (1) Development (1) Context (1) Alternative treatment (1) Origin (1) Xenografts (1) Lymphoblastic leukemia (1) Glucocorticoids (1) Gene expression (1) Fusion (1) Cooperation (1) Anthracyclines (1) Agent (Philosophy) (1) Genomics (1) Mutation (1) Origin (1) résistance (1) maladie (1)